Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Cryosite Limited ( (AU:CTE) ).
Cryosite Limited announced a change in the director’s interest, with Mark Kerr acquiring an additional 231,453 fully paid ordinary shares, bringing his total to 7,231,453 shares. This change, conducted through both off-market and on-market trades, reflects a strategic move in the company’s governance structure, potentially impacting its market positioning and stakeholder interests.
More about Cryosite Limited
Cryosite Limited operates in the biotechnology sector, focusing on the storage and management of biological materials. The company provides services related to the preservation of cord blood and tissue, catering primarily to healthcare providers and research institutions.
YTD Price Performance: -11.18%
Average Trading Volume: 8,226
Technical Sentiment Signal: Sell
Current Market Cap: A$36.85M
Learn more about CTE stock on TipRanks’ Stock Analysis page.